Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non Small-Cell Lung Cancer
Karrison, T. G., Maitland, M. L., Stadler, W. M., Ratain, M. J.Volume:
99
Language:
english
Journal:
JNCI Journal of the National Cancer Institute
DOI:
10.1093/jnci/djm158
Date:
October, 2007
File:
PDF, 105 KB
english, 2007